Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

No link found between specific genes and female pattern hair loss.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

PCOS may increase the risk of certain cancers.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Certain gene variants can influence acne risk and severity.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Canakinumab's effect on COVID-19 outcomes is unclear.

Probiotics may help with hair growth and dandruff, but more research is needed.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Social media can help compare the effectiveness and safety of new arthritis medications.

Ixekizumab has known and some unexpected side effects.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Female pattern hair loss and polycystic ovary syndrome are often linked.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

PRP and minoxidil are similarly effective for hair density, but PRP has higher patient satisfaction.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

VLDL could be an early warning sign for male pattern baldness.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.